Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.

ABSTRACT:

Background

Pulmonary arterial hypertension (PAH) is a chronic disease that ultimately progresses to right-sided heart failure (HF) and death. Close monitoring of pulmonary artery pressure (PAP) and right ventricular (RV) function allows clinicians to appropriately guide therapy. However, the burden of commonly used methods to assess RV hemodynamics, such as right heart catheterization, precludes frequent monitoring. The CardioMEMS HF System (Abbott) is an ambulatory implantable hemodynamic monitor, previously only used in patients with New York Heart Association (NYHA) class III HF. In this study, we evaluate the feasibility and early safety of monitoring patients with PAH and right-sided HF using the CardioMEMS HF System.

Methods

The CardioMEMS HF sensors were implanted in

SUBMITTER: Benza RL 

PROVIDER: S-EPMC6904858 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature